Calcium hydroxylapatite (Radiesse): how it stimulates collagen
A biostimulator that also fills — the microsphere-fibroblast mechanism, hyperdilution, and the fact that hyaluronidase does not reverse it.
Calcium hydroxylapatite sits awkwardly between categories. It fills like a filler and stimulates like a biostimulator, and understanding both halves is the only way to use it sensibly — or to understand why it behaves differently from hyaluronic acid.
Composition
The product is a suspension: calcium hydroxylapatite microspheres, described in the literature as roughly 30% of the volume at 25–45 μm diameter, carried in a carboxymethyl cellulose gel making up the remaining 70%.
That two-part structure explains its behaviour over time. The gel carrier provides immediate volume and then gradually dissipates. The microspheres remain, and it is what happens around them that produces the durable effect.
The regenerative mechanism
Fibroblasts adhere to the microspheres, which act as a scaffold. As the microspheres undergo biodegradation, that cell-biomaterial interaction drives continued production of collagen and elastin.
The systematic literature describes increases not only in collagen but in elastin, vasculature, proteoglycans and fibroblast populations. Comparative work reports significantly more collagen I and elastin synthesis in calcium hydroxylapatite-treated tissue than in hyaluronic acid-treated tissue.
Clinical effect is generally described as lasting 12 to 18 months, with histological evidence of ongoing collagen production continuing past the point at which the visible correction has faded.
Hyperdilution
The technique that has driven much of the recent interest. Diluting the product substantially changes what it does: instead of a volumising implant it becomes a diffuse biostimulatory treatment spread through a tissue plane, used for skin quality rather than contour.
Published work covers hyperdiluted use for neck rejuvenation with ultrasonographic assessment, and for biostimulatory sculpting of the midface and lower face. The neck is a region where conventional volumising has little to offer and skin quality is the actual complaint, which is why the technique found an audience there.
Dilution ratios, injection planes and volumes are technique decisions that belong with the practitioner and the product information, not on a reference page.
The safety point that gets skipped
Hyaluronidase does not dissolve calcium hydroxylapatite.
This is the single most important practical difference from hyaluronic acid, and it changes the risk calculation completely. A vascular occlusion caused by hyaluronic acid has an antidote and a published emergency protocol. An occlusion caused by calcium hydroxylapatite does not. Management is supportive while the tissue survives or does not.
For the same reason, an unsatisfactory aesthetic result cannot simply be dissolved away. It resorbs on its own schedule.
The reasonable inference — and the one the complication literature supports — is that a non-reversible product asks for more conservatism in high-risk regions than a reversible one, not less.
